Prognostic impact of blood group O in MGMT-methylated glioblastoma patients receiving radiochemotherapy with temozolomide and lomustine.
Journal of neuro-oncology
View this publicationMember
Journal of neuro-oncology
View this publicationDiagnostics (Basel, Switzerland)
View this publicationEuropean radiology experimental
View this publication